In this article, we analyze myopathies with cores, for which an association to malignant hyperthermia (MH) has been suggested. We discuss the clinical features, the underlying genetic defects, subsequent effects on cellular calcium metabolism, and in vitro muscle responses to MH triggers. We describe in detail central core disease, multiminicore disease, and nemaline rod myopathy. We categorize the diseases according to the affected proteins and discuss the risk for MH, which is high or theoretically possible when the calcium-conducting proteins are affected
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational gene...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...
We have compared the ultrastructure of skeletal muscle biopsies from patients that have survived a [...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle in which volatile anest...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
International audienceMalignant hyperthermia susceptibility (MHS) is a subclinical pharmacogenetic d...
Background: Malignant hyperthermia (MH) susceptibility is a pharmacogenetic disorder of intracellula...
Malignant hyperthermia (MH) is an uncommon, lifethreatening pharmacogenetic disorder of the skeletal...
Early studies indicated that the pharmacogenetic disorder, malignant hyperthermia (MH), was inherite...
Exertional heat illness (EHI) is a clinically important disorder, notifiable in military personnel, ...
Malignant hyperthermia (MH) is a rare and life-threatening pharmacogenetic disorder triggered by vol...
Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often link...
Abstract: Malignant hyperthermia is a life-threatening disorder, which can be prevented by avoiding ...
This article reviews advancements in the genetics of malignant hyperthermia, new technologies and ap...
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder. Numerous mutations of ...
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational gene...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...
We have compared the ultrastructure of skeletal muscle biopsies from patients that have survived a [...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle in which volatile anest...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
International audienceMalignant hyperthermia susceptibility (MHS) is a subclinical pharmacogenetic d...
Background: Malignant hyperthermia (MH) susceptibility is a pharmacogenetic disorder of intracellula...
Malignant hyperthermia (MH) is an uncommon, lifethreatening pharmacogenetic disorder of the skeletal...
Early studies indicated that the pharmacogenetic disorder, malignant hyperthermia (MH), was inherite...
Exertional heat illness (EHI) is a clinically important disorder, notifiable in military personnel, ...
Malignant hyperthermia (MH) is a rare and life-threatening pharmacogenetic disorder triggered by vol...
Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often link...
Abstract: Malignant hyperthermia is a life-threatening disorder, which can be prevented by avoiding ...
This article reviews advancements in the genetics of malignant hyperthermia, new technologies and ap...
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder. Numerous mutations of ...
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational gene...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...
We have compared the ultrastructure of skeletal muscle biopsies from patients that have survived a [...